Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study.

Béatrice M F WinkelEmma SchramHendrik GremmelsSylvia DebastRob SchuurmanAnnemarie WensingMarc BontenEdwin GoedhartMarije Hofstranull null

Published in: BMJ open (2021)

The Panbio COVID-19 Ag rapid test identifies 81%-90% of presymptomatic and early asymptomatic SARS-CoV-2 infections with high specificity. This test may therefore be adopted in testing strategies such as targeted screening of specific populations where prevalence is low.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
risk factors
genome wide
dna methylation
quantum dots
gene expression